NCT01560143View on ClinicalTrials.gov

Pharmacokinetics Of Tigecycline In Morbidly Obese Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Obesity
Interventions
DRUG

Tigecycline

100 mg IV as a single infusion over 30 minutes

Trial Locations (1)

12186

Albany College of Pharmacy, Albany

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Manjunath Prakash Pai

OTHER

NCT01560143 - Pharmacokinetics Of Tigecycline In Morbidly Obese Subjects | Biotech Hunter | Biotech Hunter